Manuela Funke-Chambour

1.9k total citations · 2 hit papers
43 papers, 950 citations indexed

About

Manuela Funke-Chambour is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Manuela Funke-Chambour has authored 43 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Manuela Funke-Chambour's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Sarcoidosis and Beryllium Toxicity Research (8 papers). Manuela Funke-Chambour is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Sarcoidosis and Beryllium Toxicity Research (8 papers). Manuela Funke-Chambour collaborates with scholars based in Switzerland, Germany and Canada. Manuela Funke-Chambour's co-authors include Thomas Geiser, Sabina A. Guler, Christian F. Clarenbach, Pierre‐Olivier Bridevaux, Christophe von Garnier, Thomas Koudstaal, Martin Brutsche, Michael Kreuter, Philip L. Molyneaux and Marlies Wijsenbeek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Radiology.

In The Last Decade

Manuela Funke-Chambour

39 papers receiving 938 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

2021 265 citations Sabina A. Guler, Lukas Ebner et al. European Respiratory Journal profile →
Pulmonary fibrosis: from pathogenesis to clinical decision-making

2023 103 citations Manuela Funke-Chambour et al. profile →

Peers

Countries citing papers authored by Manuela Funke-Chambour

Since Specialization

Citations

This map shows the geographic impact of Manuela Funke-Chambour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Funke-Chambour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Funke-Chambour more than expected).

Fields of papers citing papers by Manuela Funke-Chambour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Funke-Chambour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Funke-Chambour. The network helps show where Manuela Funke-Chambour may publish in the future.

Co-authorship network of co-authors of Manuela Funke-Chambour

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Funke-Chambour. A scholar is included among the top collaborators of Manuela Funke-Chambour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Funke-Chambour. Manuela Funke-Chambour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury 2025 ·Respiratory Research ·(unknown), Carlos Machahua, Thomas M. Marti, (unknown), Savvina Chortarea, (unknown), Christophe von Garnier, Patrick Dorn, Kleanthis Fytianos, Manuela Funke-Chambour	1
2	Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosis 2024 ·JCI Insight ·(unknown), (unknown), (unknown), Huijuan Wang, (unknown), Mamta Chabria, Grazia M. Cereghetti, Hubert S. Gabryś, Stephanie Tanadini‐Lang, Anne‐Christine Uldry, Manfred Heller, Stijn E. Verleden, Kerstin Klein, (unknown), Manuela Funke-Chambour, Lukas Ebner, Oliver Distler, Britta Maurer, Janine Gote-Schniering	4
3	Circulating calprotectin levels four months after severe and non-severe COVID-19 2023 ·BMC Infectious Diseases ·(unknown), Carlos Machahua, (unknown), (unknown), Lise Piquilloud, Maura Prella, (unknown), Christophe von Garnier, Manuela Funke-Chambour	1
4	Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis 2023 ·ERJ Open Research ·(unknown), Cécile Daccord, Eric Bernasconi, Martin Brutsche, Christian F. Clarenbach, Katrin Hostettler, Sabina A. Guler, (unknown), Niki Ubags, Manuela Funke-Chambour, Christophe von Garnier	3
5	Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis 2023 ·BMJ Open Respiratory Research ·Tyler Pitre, Letícia Kawano-Dourado, (unknown), (unknown), Gareth Leung, (unknown), Chunjuan Zhai, Wendy Adams, Manuela Funke-Chambour, (unknown), Iain Stewart, Christopher J. Ryerson, Gísli Jenkins, Dena Zeraatkar	9
6	MRI Shows Lung Perfusion Changes after Vaping and Smoking 2022 ·Radiology ·(unknown), Grzegorz Bauman, Insa Korten, Orso Pusterla, Florian Singer, Michael Ith, (unknown), Anna Schoeni, Johannes T. Heverhagen, Andreas Christe, Nicolas Rodondi, Oliver Bieri, Thomas Geiser, Reto Auer, Manuela Funke-Chambour, Lukas Ebner	16
7	Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study 2022 ·Respiration ·Alexandra Lenoir, Andreas Christe, Lukas Ebner, Catherine Beigelman‐Aubry, Pierre‐Olivier Bridevaux, Martin Brutsche, Christian F. Clarenbach, Berra Erkoşar, Christian Garzoni, Thomas Geiser, Sabina A. Guler, Dik Heg, Frédéric Lador, Marco Mancinetti, Sebastian R. Ott, Lise Piquilloud, Maura Prella, Yok‐Ai Que, Christophe von Garnier, Manuela Funke-Chambour	16
8	Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges 2022 ·ERJ Open Research ·(unknown), Carlos Machahua, Venerino Poletti, J. Cadranel, Athol U. Wells, Manuela Funke-Chambour	16
9	Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study 2022 ·Respiratory Research ·Sabina A. Guler, Carlos Machahua, Thomas Geiser, Gregor J. Kocher, Thomas M. Marti, (unknown), Verdiana Trappetti, Christopher J. Ryerson, Manuela Funke-Chambour	11
10	Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts 2021 ·BMJ Open Respiratory Research ·Carlos Machahua, Sabina A. Guler, Michael P. Horn, Lurdes Planas‐Cerezales, Ana Montes‐Worboys, Thomas Geiser, María Molina‐Molina, Manuela Funke-Chambour	22
11	Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19 2021 ·Frontiers in Medicine ·Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio	32
12	Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study 2021 ·Respiratory Research ·Sabina A. Guler, (unknown), Sabina Berezowska, Thomas Geiser, Lukas Ebner, Manuela Funke-Chambour	5
13	Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID 2021 ·Respiration ·Manuela Funke-Chambour, Pierre‐Olivier Bridevaux, Christian F. Clarenbach, Paola M. Soccal, Laurent Nicod, Christophe von Garnier, (unknown)	38
14	Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease 2021 ·CHEST Journal ·Yet H. Khor, (unknown), (unknown), Kerri A. Johannson, Ian Glaspole, Sabina A. Guler, Manuela Funke-Chambour, Thomas Geiser, Nicole Goh, Christopher J. Ryerson	26
15	Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study breakdown → 2021 ·European Respiratory Journal ·Sabina A. Guler, Lukas Ebner, (unknown), Pierre‐Olivier Bridevaux, Martin Brutsche, Christian F. Clarenbach, Christian Garzoni, Thomas Geiser, Alexandra Lenoir, Marco Mancinetti, (unknown), Sebastian R. Ott, Lise Piquilloud, Maura Prella, Yok‐Ai Que, (unknown), Christophe von Garnier, Manuela Funke-Chambour	265
16	Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls 2020 ·Respiratory Research ·(unknown), (unknown), (unknown), Nina Hobi, (unknown), Cédric Simillion, (unknown), (unknown), Lars Knudsen, Thomas Geiser, Manuela Funke-Chambour	33
17	Multidisziplinäre Diskussion – der Goldstandard der Diagnostik interstitieller Lungenerkrankungen 2019 ·Der Pathologe ·Sabina Berezowska, Manuela Funke-Chambour, Alexander Pöllinger, Stephan Schäfer	1
18	Medium throughput breathing human primary cell alveolus-on-chip model 2018 ·Scientific Reports ·Janick D. Stucki, Nina Hobi, (unknown), A. Stucki, Nicole Schneider‐Daum, Claus‐Michael Lehr, Hanno Huwer, Manfred Frick, Manuela Funke-Chambour, Thomas Geiser, Olivier T. Guenat	126
19	Perioperative Lung Function Monitoring for Anatomic Lung Resections 2017 ·The Annals of Thoracic Surgery ·Gregor J. Kocher, (unknown), (unknown), Manuela Funke-Chambour, Sebastian R. Ott, Patrick Dorn, (unknown), Ralph A. Schmid	5
20	Multidisciplinary discussion for diagnosis of interstitial lung disease in real life 2016 ·Swiss Medical Weekly ·Sabina A. Guler, Sabina Berezowska, Andreas Christe, Thomas Geiser, Manuela Funke-Chambour	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact